Europe's Extracellular Vesicle Researchers Unite to Accelerate Drug Discovery
Over 280 scientists from 28 countries gathered in Belgrade for Europe's second major symposium on extracellular vesicles—tiny particles with potential as disease biomarkers and therapeutics. The event signals growing commercial and clinical momentum in a field that could reshape diagnostics and regenerative medicine within the decade.
Originaltitel: Report on the 2nd MObility for Vesicle research in Europe (MOVE) symposium-2024
<p>The 2nd MObility for Vesicle research in Europe (MOVE) Symposium, held in Belgrade-Serbia, from October 8 to 11, 2024, showcased the dynamic and interdisciplinary nature of extracellular vesicles (EVs) research in Europe. Organized by eight National EV Societies under the MOVE initiative, the event gathered over 280 attendees from 28 countries, promoting collaboration and scientific exchange. The symposium featured eight keynote lectures, 48 oral and 126 poster presentations, and sessions dedicated to EV-related tools and industry innovations. The scientific program was structured around seven core themes: EV biogenesis and signal transmission, roles of EVs in health and disease, EV-based biomarkers, interspecies communication, novel EV preparation and analysis techniques, therapeutic and regenerative applications, and the manufacturing of native and engineered EV products. Supported by 18 sponsors and the Ministry of science, technological development and innovation of the Republic of Serbia, the symposium also highlighted the MOVE Fellowship Program and offered rich networking opportunities. This landmark event reinforced MOVE's promising mission to promote excellence, mobility, and resource sharing in EV research across Europe.</p>